Common Contracts
5 similar Severance Agreement contracts by Maxcyte, Inc.
SEVERANCE AGREEMENTSeverance Agreement • January 26th, 2024 • Maxcyte, Inc. • Services-commercial physical & biological research • Maryland
THIS SEVERANCE AGREEMENT is made as of March 10, 2023 (the “Effective Date”), by and between MaxCyte, Inc., a Delaware corporation (the "Company"), and Cenk Sumen (the "Executive").
SEVERANCE AGREEMENTSeverance Agreement • March 28th, 2023 • Maxcyte, Inc. • Services-commercial physical & biological research • Maryland
THIS SEVERANCE AGREEMENT is made as of March 27, 2023 (the “Effective Date”), by and between MaxCyte, Inc., a Delaware corporation (the "Company"), and Douglas J. Swirsky (the "Executive").
SEVERANCE AGREEMENTSeverance Agreement • July 26th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research • Maryland
THIS SEVERANCE AGREEMENT is made as of July 20, 2021 (the “Effective Date”), by and between MaxCyte, Inc., a Delaware corporation (the "Company"), and Doug Doerfler (the "Executive").
SEVERANCE AGREEMENTSeverance Agreement • July 26th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research • Maryland
THIS SEVERANCE AGREEMENT is made as of January 21, 2021 (the “Effective Date”), by and between MaxCyte, Inc., a Delaware corporation (the "Company"), and Amanda Murphy (the "Executive").
SEVERANCE AGREEMENTSeverance Agreement • July 26th, 2021 • Maxcyte, Inc. • Services-commercial physical & biological research • Maryland
THIS SEVERANCE AGREEMENT is made as of January 11, 2021 (the “Effective Date”), by and between MaxCyte, Inc., a Delaware corporation (the "Company"), and Brad Calvin (the "Executive").
